Nikkho, S. M., Richter, M. J., Shen, E., Abman, S. H., Antoniou, K., Chung, J., . . . Nathan, S. D. (2022). Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension.
Citación estilo ChicagoNikkho, Sylvia M., et al. Clinical Significance of Pulmonary Hypertension in Interstitial Lung Disease: A Consensus Statement From the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. 2022.
Cita MLANikkho, Sylvia M., et al. Clinical Significance of Pulmonary Hypertension in Interstitial Lung Disease: A Consensus Statement From the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. 2022.